AmplifyBio is a preclinical contract research organization that will advance the quality of human health and save lives by creating next generation platforms, tools, and services to amplify and accelerate the development of therapies and vaccines that will be accessible to millions of people.
AmplifyBio Enters into Asset Purchase Agreement with PACT Pharma
AmplifyBio adds talent, technology platforms, and discovery and characterization capabilities to close a critical gap that exists between the discovery and preclinical phases of drug development
Molecular and Cellular Assays ● Cell and Protein Engineering Bioinformatics ● Immunoassays
"I'm excited to lead AmplifyBio on a journey from leading preclinical CRO to a truly integrated ecosystem for the commercialization of advanced therapies"
